|
NUPL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.60869104096173E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.39293046383682E-12 |
| Normal-vs-Stage2 |
1.05909947478722E-10 |
| Normal-vs-Stage3 |
2.33146835171283E-15 |
| Normal-vs-Stage4 |
4.20785628563181E-12 |
| Stage1-vs-Stage2 |
3.279800E-01 |
| Stage1-vs-Stage3 |
2.085600E-01 |
| Stage1-vs-Stage4 |
2.694400E-01 |
| Stage2-vs-Stage3 |
9.690600E-01 |
| Stage2-vs-Stage4 |
9.573600E-01 |
| Stage3-vs-Stage4 |
9.173400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.23470156110761E-13 |
| Normal-vs-AfricanAmerican |
2.824000E-04 |
| Normal-vs-Asian |
1.40699996098448E-09 |
| Caucasian-vs-AfricanAmerican |
1.654280E-02 |
| Caucasian-vs-Asian |
5.736800E-01 |
| AfricanAmerican-vs-Asian |
1.173020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72273306731086E-12 |
| Normal-vs-Female |
4.73288075397704E-12 |
| Male-vs-Female |
9.861500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.36130012712488E-11 |
| Normal-vs-Age(41-60Yrs) |
2.09721129351692E-13 |
| Normal-vs-Age(61-80Yrs) |
2.13706830010096E-12 |
| Normal-vs-Age(81-100Yrs) |
9.182500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.378300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.047160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.540600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.769600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.930000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.812200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.681600E-01 |
| Classical-VS-Follicular |
6.507900E-02 |
| Classical-VS-Other |
3.004600E-01 |
| Classical-VS-Normal |
8.14960321449121E-11 |
| Tall-VS-Follicular |
8.878800E-01 |
| Tall-VS-Other |
7.130800E-01 |
| Tall-VS-Normal |
6.44919673220556E-11 |
| Follicular-VS-Other |
7.223000E-01 |
| Follicular-VS-Normal |
1.72861724934137E-12 |
| Other-VS-Normal |
3.762800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04916075827077E-13 |
| Normal-vs-N1 |
9.98778837413283E-12 |
| N0-vs-N1 |
8.691200E-01 |
|
|
